Dipeptide "alaptide" prevented impairments in spontaneous behavior produced with trimethyltin in male rats

Neuroendocrinology Letters

Volumn 29, Issue 6, 2008, Pages 917-923

  Hliňák, Zdeněk ^a   Krejčí, Ivan ^a   Hynie, Sixtus ^a   Klenerová, Věra ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alaptide; Open field; Rat; Spontaneous behavior; Trimethyltin

Indexed keywords

ALAPTIDE; DIPEPTIDE; TRIMETHYLTIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG MECHANISM; MALE; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; OUTCOME ASSESSMENT; RAT; TREATMENT DURATION;

EID: 59849115378     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Ali SF, LeBel CP, Bondy SC (1992). Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology 13: 637-648.
2. Bohus GL, Borrell J, Koohaas JM, Nyakas C, Buwalda B, Compaan JC, Roozendaal B (1993). The neurohypophysial peptides, learning, and memory processing. Ann NY Acad Sci: 689: 285-299.
3. Dantzer R (1998). Vasopressin, gonadal steroids and social recognition. Prog Brain Res 119: 409-414.
4. De Wied D (1997). Neuropeptides in learning and memory processes. Behav Brain Res 83: 83-90.
5. De Wied D, Gaffori O, van Ree JM, de Jong W (1984). Central target for the behavioural effects of vasopressin neuropeptides. Nature 308: 276-278.
6. Dorman DC (2000). An integrative approach to neurotoxicology. Toxicol Pathol 28: 37-42.
7. Dyer RS, Deshields TL, Wonderlin WF (1982). The trimethyltin syndrome in rats. Neurobehav Toxicol Teratol 4: 127-133.
8. Earley B, Burke M, Leonard BE (1989). Effects of captopril on locomotor activity, passive avoidance behaviour and spatial memory tasks in the trimethyltin-treated rat. Neuropsychobiology 22: 49-56.
9. Earley B, Burke M, Leonard BE, Gouret CJ, Junien JL (1990). A comparison of the psychopharmacological profiles of phencyclidine, ketamine and (+)SKF 10,047 in the trimethyltin rat model. Neuropharmacology 29: 695-703.
10. Earley B, Burke M, Leonard BE (1992). Behavioural, biochemical and histological effects of trimethyltin (TMT) induced brain damage in the rat. Neurochem Int 21: 351-366.
11. Gudasheva TA, Boyko SS, Ostrovskaya RU, Voronina TA, Akparov VK, Trofimov SS et al. (1997). The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine. Eur J Drug Metab Pharmacokinetics 22: 245-252.
12. Gudasheva TA, Voronina TA, Ostrovskaya RU, Royantev GG, Vasilevich NI, Trofimov SS et al. (1996). Synthesis and antiamnesic activity of a series of N-acylprolyl-containing dipeptides. Eur J Med Chem 31: 151-157.
13. Hagan JJ, Jansen JH, Broekkamp CL (1988). Selective behavioural impairment after acute intoxication with trimethyltin (TMT) in rats. Neurotoxicology 9: 53-74.
14. Hliňák Z, Krejčí I (1991). Social recognition in male rats: age differences and modulation by MIF-1 and alaptide. Physiol Res 40: 59-67.
15. Hliňák Z, Krejčí I (1992). Prolonged social recognition in male rats treated with alaptide and oxiracetam. Behav Pharmacol 3: 129-131.
16. Hliňák Z, Krejčí I (2005). Oxiracetam pre- but not post-treatment prevented social recognition deficits produced with trimethyltin in rats. Behav Brain Res 161: 213-219.
17. Hliňák Z, Krejčí I, Hondlík J, Yamamoto A (1990). Behavioral consequences of sodium nitrite hypoxia in male rats: amelioration with alaptide treatment. Methods Find Exp Clin Pharmacol 12: 385-393.
18. Hliňák Z., Vinšová J, Kasafírek E (1996). Effect of alaptide, its analogues and oxiracetam on memory for an elevated plus-maze in mice. Eur J Pharmacol 14: 1-7.
19. Ishikawa K, Kubo T, Shibanoki S, Matsumoto A, Hata H, Asai S (1997). Hippocampal degeneration inducing impairment of learning in rats: model of dementia. Behav Brain Res 83: 39-44.
20. Johnston CT, Dunn A, Robinson C, Walsh TJ, Swartzwelder HS (1984). Alterations in regulatory and locomotor behaviors following trimethyltin exposure in the rat: a time and dose analysis. Neurosci Lett 47: 99-106.
21. Kasafírek E, Rybák M, Krejčí I, Šturs A, Křepela E, Šedo A (1992a). Two-step generation of spirocyclic dipeptides from linear peptide ethyl ester precursors. Life Sci 50: 187-193.
22. Kasafírek E, Šturc A, Roubalová A (1992b). Linear tri- and tetra-peptides acting as prodrugs. Collect Czech Chem Commun 57: 179-187.
23. Keilhoff G, Wolf G, Štastný F (1991). Effects of MK-801, ketamine and alaptide on quinolinate models in the maturing hippocampus. Neuroscience 42: 379-385.
24. Koczyk D, Jablonska B (1998). Spatiotemporal changes in hippocampal NMDA receptor binding as a consequence of trimethyltin neurotoxicity in the rat. Neurosci Lett 251: 29-32.
25. Kovacs GL, Vecsei L, Telegdy G (1978). Opposite action of oxytocin to vasopressin in passive avoidance behavior in rats. Physiol Behav 20: 801-803.
26. Kovacs GL, Velhuis HD, Versteeg DH, de Wied D (1986). Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structure. Brain Res 371: 17-24.
27. Krejčí I (1987). Effect of nootropic drugs on disruption of conditioned taste aversion by ECS. Act Nerv Sup 29: 217-218.
28. Krejčí I, Dlabač A (1984). Bar-pressing for water reward: effects of nootropic drugs and peptides on discrimination learning in rats. Act Nerv Sup 26: 103-111.
29. Kreǰaci I, Dlabač A, Vanžura J, Kosnar J (1986). Effect of a spirocyclic cyclodipeptide derivate of MIF on passive avoidance behavior and amnesia in rats. Act Nerv Sup 28: 241-246.
30. Krejčí I, Kupková B, Dlabač (1981). A Passive avoidance behavior: opposite effects of oxytocin analogs with agonist and antagonist properties. Regul. Pept. 2 285-291.
31. Lapka R (1991). Pharmacokinetics and brain entry of alaptide, a novel nootropic agent, in mice, rats and rabbits. J Pharm Pharmacol 43: 874-876.
32. Lebedev AA, Panchenko GN, Shabanov PD (2000). Effect of the melanostatin analogue alaptide on dopamine-dependent behavior in rats reared in isolation. Zh Vysh Nerv Deiat Im IP Pavlova 50: 716-719.
33. Manning-Sayi J, Leonard BE (1989). Studies on the nootropic potential of some angiotensin converting enzyme inhibitors in mouse. Prog Neuropsychopharmacol Biol Psychiatry 13: 953-962.
34. Martin F, Corrigan FM, Donard OF, Kelly J, Beson JA, Horrobin D (1997). Organotin compounds in trimethyltin-treated rats and human brain in Alzheimer's disease. Hum Exp Toxicol 16: 512-515.
35. Maurice T, Phan VL, Noda Y, Yamada K, Privat A, Nabeshima T (1999). The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma receptor ligands involves both sigmal and sigma2 sites. Br J Pharmacol 127: 35-342.
36. McMillan DE, Wenger GR (1985). Neurobehavioral toxicology of trialkyltins. Pharmacol Rev 37: 365-379.
37. Moser VC (1996). Rat strain- and gender-related differences in neurobehavioral screening: acute trimethyltin neurotoxicity. J Toxicol Environ Health 47: 567-586.
38. Nedvidkova J, Kasafirek E, Nedvidek J, Pacak K, Schreiber V (1994). An analog of MIF, alaptide: effect on serum prolactin, dopamine receptors and growth of rat adenohypophysis. Endocr Res 20: 39-46.
39. Nishimura T, Schwarzer C, Furtinger S, Imai H, Kato N, Sperk G (2001). Changes in the GABA-ergic system induced by trimethyltin application in the rat. Brain Res Mol Brain Res 97: 1-6.
40. O'Connell AW, Earley B, Leonard BE (1994a). Changes in muscarinic (M1 and M2 subtypes) and phencyclidine receptor density in the rat brain following trimethyltin intoxication. Neurochem Int 25: 243-252.
41. O'Connell AW, Earley B, Leonard BE (1994b).The neuroprotective effect of tacrine on trimethyltin induced memory and muscarinic receptor dysfunction in the rat. Neurochem Int 25: 556-566.
42. O'Connell AW, Earley B, Leonard BE (1996). The sigma ligand JO 1784 prevents trimethyltin-induced behavioural and sigma-receptor dysfunction in the rat. Pharmacol Toxicol 78: 296-302.
43. Rádl S, Kasafírek E, Krejčí I (1990). Alaptide. Drugs Future 15: 445-447.
44. Reiter LW, Ruppert PH (1984). Behavioral toxicity of trialkyltin compounds: a review. Neurotoxicology 5:177-186.
45. Ruppert PH, Walsh TJ, Reiter LW, Dyer RS (1982). Trimethyltin induced hyperactivity: time course and pattern. Neurobehav Toxicol Teratol 4: 135-139.
46. Shin EJ, Nah SY, Chae JS, Bing G, Shin SW et al. (2007). Dextromethorphan attenuates trimethyltin-induced neurotoxicity via sigma1 receptor activation in rats. Neurochem Int 50: 791-799.
47. Siegel S. (1956). Nonparametric statistics for the behavioral sciences. McGraw-Hill Book Company, Inc.
48. Šulcová A, Krejčí I (1991). Effects of MIF-1 and its cyclic derivative alaptide on agonistic behaviour in mice. Homeost Health Dis 33:167-168.
49. Tsutsumi S, Akaike M, Arimitsu H, Imai H, Kato N (2002). Circulating corticosterone alters the rate of neuropathological and behavioral changes induced by trimethyltin in rats. Exp Neurol 173: 86-94.
50. Valchář M, Krejčí I, Kasafírek E, Schuh J, Dlabač A (1985). The use of striatal dopaminergic supersensitivity for the evaluation of drugs with possible antidyskinetic properties. Pol J Pharmacol Pharm 37: 311-315.
51. Walter R, Hoffman PL, Flexner JB, Flexner LB (1975). Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia. Proc Nat Acad Sci USA 72: 4180-4184.
52. Walter R, van Ree JM, de Wied D (1978). Modification of conditioned behavior of rats by neurohypophyseal hormones and analogues. Proc Nat Acad Sci USA 75: 2493-2496.